Target intelligence / Profile preview

Wiskott-Aldrich syndrome protein family member 1 (WASF1) mRNA (WASF1 mRNA)

Target
WASF1 mRNA
Molecular classification
Messenger RNA, Actin-binding protein (encoded), Scaffolding protein (encoded), WASP family (encoded)
01

Overview

Wiskott-Aldrich syndrome protein family member 1 (WASF1) mRNA is the transcript encoding the WASF1 protein, also known as WAVE1, which is a critical regulator of actin cytoskeleton dynamics (UniProt P46089). The encoded protein functions as a core component of the WAVE regulatory complex (WRC), activating the Arp2/3 complex to promote branched actin polymerization essential for cell motility and lamellipodia formation (PubMed: 10564660). In the brain, WASF1 mRNA expression is vital for neuronal development, axonal outgrowth, and synaptic plasticity (PubMed: 29335605). Pathologically, elevated levels of WASF1 mRNA are associated with increased invasion and metastasis in various cancers, while mutations in the gene lead to a rare neurodevelopmental disorder (PubMed: 25670297; NIH: GARD). As a therapeutic target, WASF1 mRNA is being explored for modulation via RNA-based technologies such as antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). These approaches aim to reduce aberrant protein production in oncogenic settings or potentially address toxic gain-of-function in specific genetic conditions. Monitoring the levels of WASF1 mRNA serves as a key biomarker for assessing the efficacy of these transcript-targeted therapies.

Other names
WAVE1 mRNASCAR1 mRNAWASF1 transcriptWiskott-Aldrich syndrome protein family member 1 transcript
02

Mechanism of action

Antisense inhibition and RNA interference targeting the transcript to prevent translation or induce degradation.

03

Biological functions

Protein synthesis templateActin cytoskeleton organization (via encoded protein)Cell migration regulationNeuronal developmentSynaptic plasticity regulation
04

Disease associations

CancerNeurodevelopmental disorderAlzheimer's disease
05

Safety considerations

Off-target effects of oligonucleotidesPotential neurotoxicity from protein depletionImpairment of synaptic plasticity
06

Interacting drugs

Experimental antisense oligonucleotides

1 more in the full profile.

07

Biomarkers

WASF1 mRNA expression levelsWAVE1 protein levels

Beyond the preview

Go deeper on Wiskott-Aldrich syndrome protein family member 1 (WASF1) mRNA (WASF1 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wiskott-Aldrich syndrome protein family member 1 (WASF1) mRNA (WASF1 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call